Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
This release was issued on November 8, 2024 and speaks only as of that date. It has not been updated. For Zentek’s current disclosure, see SEDAR+ and EDGAR.
The full text of this release is available on the wire service.